Results 211 to 220 of about 4,732,777 (361)

Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group

International Journal of Cancer, EarlyView.
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea, Pierre Loap, Sofiane Allali, Alain Fourquet, Kim Cao, Youlia Kirova   +5 more
wiley   +1 more source

Comparison of currently common neoadjuvant therapy strategies for rectal cancer: a three-arm retrospective study. [PDF]

Front Cell Infect Microbiol
Zhang X, An Y, Liu Y, Li G, Qiu X, Lu Y, Lin G.   +6 more
europepmc   +1 more source

Table S1 from Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Breast Cancer Cells to Chemotherapy and Reduces Neoadjuvant Therapy–induced Metastasis

, 2023
Victoria Hoskin, Abdi Ghaffari, Brian J. Laight, Sandip Sengupta, Yolanda Madarnas, Christopher J.B. Nicol, Bruce E. Elliott, Sonal Varma, Peter A. Greer   +8 more
openalex   +1 more source

Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study

International Journal of Cancer, EarlyView.
What's New? This study evaluated patient characteristics and treatment strategies in stages II and III HR+/HER2− breast cancer. Neoadjuvant systemic therapy frequently facilitated breast‐conserving procedures and less invasive axillary surgery. Approximately half of the patients undergoing primary surgery received a mastectomy, and all with positive ...
Layla Andour, Judith R. Kroep, Hein Putter, Rob A. E. M. Tollenaar, Wilma E. Mesker, Marieke E. Straver   +5 more
wiley   +1 more source

Progress in surgical management strategies after neoadjuvant therapy in breast cancer. [PDF]

Ann Med
Zhu R, Kong L, Sun S.
europepmc   +1 more source

Supplementary Figure S1 from Biomarker Data from the Phase III KATHERINE Study of Adjuvant T-DM1 versus Trastuzumab for Residual Invasive Disease after Neoadjuvant Therapy for HER2-Positive Breast Cancer

, 2023
Carsten Denkert, Chiara Lambertini, Peter A. Fasching, Katherine L. Pogue–Geile, Max S. Mano, Michael Untch, Norman Wolmark, Chiun‐Sheng Huang, Sibylle Loibl, Eleftherios P. Mamounas, Charles E. Geyer, Peter C. Lucas, Thomas Boulet, Chunyan Song, Gail D. Lewis Phillips, Małgorzata Nowicka, Sanne de Haas, Mark Basik   +17 more
openalex   +1 more source

Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: A population‐based comparison

International Journal of Cancer, EarlyView.
What's New? Marked differences in esophageal and gastric cancer survival rates exist between the Netherlands and Belgium, for reasons that remain unclear. In this study, the authors in‐vestigated these differences and attempted to identify contributing factors.
Benthe H. Doeve, Steven C. Kuijper, Geert Silversmit, Lien van Walle, Philippe Nafteux, Camiel Rosman, Pauline A. J. Vissers, Paul Jeene, Laurens V. Beerepoot, Sarah Derks, Amine Karimi, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven   +13 more
wiley   +1 more source

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors. [PDF]

Nat Commun
Magbanua MJM, Manon NA, Wolf DM, Rivero-Hinojosa S, Ahmed Z, Sayaman RW, Tin A, Renner D, Kalashnikova E, Brown-Swigart L, Hirst GL, Yau C, Li W, Isaacs C, Shatsky RA, Clark AS, Zimmer A, Delson AL, Rodriguez A, Liu MC, Pohlmann PR, Esserman LJ, Rugo HS, DeMichele A, van 't Veer L.   +24 more
europepmc   +1 more source

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy

, 2013
Rebecca L. Glaser, Constantine Dimitrakakis   +1 more
openalex   +1 more source

Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark

International Journal of Cancer, EarlyView.
What's New? Obesity may worsen colorectal cancer prognosis, but the existing evidence remains inconclusive. This large nationwide cohort study comprehensively assessed how BMI interacts with demographic, clinical, and socioeconomic factors to influence colorectal cancer prognosis.
Cathrine F. Hjorth, Maja H. Olsen, Sinna P. Ulrichsen, Jesper Nors, Jannik Wheler, Signe Borgquist, Lene H. Iversen, Susanne O. Dalton, Deirdre Cronin‐Fenton   +8 more
wiley   +1 more source